AI and Precision Oncology: Innovations in Diagnosis and Drug Development examines the transformative role of artificial intelligence and machine learning in oncology. The book addresses the urgent need for early cancer diagnosis and effective therapeutic treatments, highlighting how technological advancements enable rapid analysis of large datasets to enhance patient outcomes. The content explores clinical applications of next-generation sequencing (NGS) integrated with AI technologies, covering risk prediction, disease detection, biomarker identification, and therapeutic target discovery. The book emphasizes the importance of bioinformatics tools in analyzing NGS data and showcases AI-powered applications that improve cancer diagnosis and prognostication.

For the academic audience, this book provides valuable insights into the latest advancements in AI and precision oncology. It equips researchers and clinicians with knowledge on personalized treatment strategies and recent clinical studies, ultimately enhancing understanding of how AI can revolutionize cancer care and improve patient management.

• Provides an in-depth exploration of how artificial intelligence and machine learning are integrated into various aspects of oncology, including diagnosis, treatment planning, and patient management
• Emphasizes the critical role of next-generation sequencing technologies in precision oncology, detailing their applications in risk prediction, biomarker identification, and therapeutic target discovery
• Highlights how AI-driven tools can assist in tailoring personalized treatment options based on genetic, environmental, and lifestyle factors